We are live on
!
Find out more
PVI
Pura Vida Investments Portfolio holdings
AUM
$14.9M
1-Year Est. Return
38.76%
This Fund
S&P 500
This Quarter
Est. Return
-11.53%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$842M
AUM Growth
-$295M
(-26%)
Cap. Flow
-$112M
Cap. Flow
% of AUM
-13.31%
Top 10 Holdings %
Top 10 Hldgs %
47.05%
Holding
143
New
42
Increased
27
Reduced
21
Closed
50
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AtriCure
ATRC
|
+$14M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$11.9M |
| 3 |
AMRN
Amarin Corp
AMRN
|
+$9.5M |
| 4 |
SI-BONE Inc
SIBN
|
+$9.49M |
| 5 |
INOV
Inovalon Holdings, Inc. Class A Common Stock
INOV
|
+$7.51M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GRFS
Grifois
GRFS
|
+$13.5M |
| 2 |
AGN
Allergan plc
AGN
|
+$13.3M |
| 3 |
BioCryst Pharmaceuticals
BCRX
|
+$7.52M |
| 4 |
CONMED
CNMD
|
+$5.18M |
| 5 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
+$4.53M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 34.76% |
| 2 | Industrials | 1.16% |
| 3 | Consumer Staples | 0.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
PUT
Cigna
CI
$73.3B
| – | – |
-22,000
| Closed | -$4.5M |
|
|
102
CONMED
CNMD
$1.48B
| – | – |
-46,330
| Closed | -$5.18M |
|
103
PUT
DaVita
DVA
$11.6B
| – | – |
-112,000
| Closed | -$8.4M |
|
|
EXAS
104
PUT
DELISTED
Exact Sciences
EXAS
| – | – |
-50,000
| Closed | -$4.62M |
|
105
CALL
Guardant Health
GH
$22.2B
| – | – |
-66,000
| Closed | -$5.16M |
|
106
PUT
Glaukos
GKOS
$11B
| – | – |
-132,000
| Closed | -$7.19M |
|
|
GRFS
107
Grifois
GRFS
$5.4B
| – | – |
-578,620
| Closed | -$13.5M |
|
108
PUT
HCA Healthcare
HCA
$89.8B
| – | – |
-22,000
| Closed | -$3.25M |
|
109
PUT
iShares US Medical Devices ETF
IHI
$3.48B
| – | – |
-654,000
| Closed | -$28.8M |
|
110
CALL
Illumina
ILMN
$29.1B
| – | – |
-53,456
| Closed | -$17.3M |
|
111
CALL
Inspire Medical Systems
INSP
$1.68B
| – | – |
-163,000
| Closed | -$12.1M |
|
112
CALL
Iovance Biotherapeutics
IOVA
$3.05B
| – | – |
-109,000
| Closed | -$3.02M |
|
113
KALA BIO
KALA
$17.1M
| – | – |
-214
| Closed | -$3.42M |
|
114
Standard BioTools
LAB
$312M
| – | – |
-1,090,830
| Closed | -$3.8M |
|
|
MASI
115
DELISTED
Masimo
MASI
| – | – |
-24,409
| Closed | -$3.86M |
|
116
CALL
Amplify Alternative Harvest ETF
MJ
$111M
| – | – |
-25,000
| Closed | -$5.14M |
|
117
CALL
Merit Medical Systems
MMSI
$5.45B
| – | – |
-142,000
| Closed | -$4.43M |
|
118
CALL
Natera
NTRA
$45.5B
| – | – |
-54,000
| Closed | -$1.82M |
|
|
119
Natera
NTRA
$45.5B
| – | – |
-76,300
| Closed | -$2.57M |
|
120
CALL
Novavax
NVAX
$1.31B
| – | – |
-327,800
| Closed | -$1.3M |
|
121
PUT
Omnicell
OMCL
$1.69B
| – | – |
-79,000
| Closed | -$6.46M |
|
122
CALL
Qiagen
QGEN
$8.88B
| – | – |
-559,232
| Closed | -$20M |
|
|
123
Qiagen
QGEN
$8.88B
| – | – |
-117,674
| Closed | -$4.22M |
|
|
124
PUT
Qiagen
QGEN
$8.88B
| – | – |
-308,379
| Closed | -$11.1M |
|
125
uniQure
QURE
$3.13B
| – | – |
-16,350
| Closed | -$1.17M |
|
Similar funds
BCA
RC
DOFI
SCI
LPC
GBCP
SCTC
M
Pura Vida Investments's Q1 2020 Portfolio in Review
As of Q1 2020, Pura Vida Investments held 143 positions worth $842M, down 26% from $1.14B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Pura Vida Investments withdrew a net $112M in Q1 2020, closing 50 positions and reducing 21 holdings. Its most notable exit was Grifois, an estimated $13.5M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 26% a quarter earlier, followed by Industrials and Consumer Staples.
Against the trend, Pura Vida Investments opened a new position in AtriCure worth $13.1M.
- Pura Vida Investments's largest Q1 2020 buy was AtriCure: 388,994 shares worth $13.1M.
- Pura Vida Investments added most to Alexion Pharmaceuticals in Q1 2020, an estimated $11.9M increase.
- Pura Vida Investments's biggest Q1 2020 reduction was DexCom, cutting an estimated $4.46M.
- Pura Vida Investments fully exited Grifois in Q1 2020, selling an estimated $13.5M.
- Pura Vida Investments's ten largest holdings make up 47% of its $842M portfolio in Q1 2020.
- Pura Vida Investments opened 42 new positions and closed 50 in Q1 2020.
- Pura Vida Investments's portfolio value fell 26% quarter-over-quarter to $842M.
Based on Pura Vida Investments's 13F filing for Q1 2020, filed 15 May 2020.